Loading…

Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study

Saved in:

Bibliographic Details
Published in:	Journal of the European Academy of Dermatology and Venereology 2020-08, Vol.34 (8), p.e416-e418
Main Authors:	Georgakopoulos, J.R., Lam, K., Sandhu, V.K., Ighani, A., Phung, M., Piguet, V., Yeung, J.
Format:	Article
Language:	English
Subjects:	Antibodies, Monoclonal, Humanized Biological Factors Dermatologic Agents - adverse effects Humans Psoriasis - drug therapy Retrospective Studies Severity of Illness Index Treatment Outcome Ustekinumab - adverse effects
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!